SNCA and Parkinson disease: This strongly suggests that DNMT3A-mediated DNA methylation contributes to STAT5B transcriptional repression, a notion corroborated by studies implicating DNMT3A in PD pathogenesis, such as its role in modulating SNCA expression through targeted methylation [39,40].